References
- Shults WT, Hoyt EF, Behrens M, MacLean J, Saul RF, Corbett JJ. Ocular neuromyotonia. A clinical description of six patients. Arch Ophthalmol 1986;104:1028–1034
- Chung SM, Lee AG, Holds JB, Roper-Hall G, Cruz OA. Ocular neuromyotonia in Graves dysthyroid orbitopathy. Arch Ophthalmol 1997;115:365–370
- Lessell S, Lessell I, Rizzo JF III. Ocular neuromyotonia after radiation therapy. Am J Ophthalmol 1986;102:766–770
- Roper-Hall G, Chung SM, Cruz OA. Ocular neuromyotonia: differential diagnosis and treatment. Strabismus 2013;21:131–136
- Morrow MJ, Kao GW, Arnold AC. Bilateral ocular neuromyotonia: oculographic correlations. Neurology 1996;46:264–266
- Giardina AS, Slagle WS, Greene AM, Musick AN, Eckermann DR. Novel case of ocular neuromyotonia associated with thyroid-related orbitopathy and literature review. Optom Vis Sci 2012;89:124–134
- Smith KJ, Macdonald WI. Spontaneous and evoked electrical discharges from a central demyelinating lesion. J Neurol Sci 1982;55:39–47
- Baker M, Bostock H. Ectopic activity in demyelinated spinal root axons of the rat. J Physiol 1992;451:539–552
- Aristodemou P, Watt L, Baldwin C, Hugkulstone C. Diplopia associated with the cosmetic use of botulinum toxin A for facial rejuvenation. Ophthal Plast Reconstr Surg 2006;22:134–136
- Shilpa PS, Kaul R, Sultana N, Bhat S. Botulinum toxin: the Midas touch. J Nat Sci Biol Med 2014;5:8–14